SAN DIEGO , May 5 / PRNewswire / -- - Evoke Pharma , Inc . , a privately-held specialty pharmaceutical company , announced today that it has initiated a Phase 2b clinical trial to evaluate EVK-001 for the treatment of adults with symptoms of diabetic gastroparesis .